Irbesartan and Klor-con m20 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Irbesartan (irbesartan) and Klor-con m20 (potassium chloride). Common drug interactions include arteriosclerosis coronary artery among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Irbesartan and Klor-con m20. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 36,414 Irbesartan users. Check the latest studies of Irbesartan.

What is Klor-con m20?

Klor-con m20 has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 2,411 Klor-con m20 users. Check the latest studies of Klor-con m20.

On Jul, 13, 2026

12 people who take Irbesartan and Klor-con m20 together, and have interactions are studied.

Irbesartan and Klor-con m20 drug interactions.

What are the common drug interactions of Irbesartan and Klor-Con M20, by gender? *:

female:

Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Asthma
Chest discomfort
Cough
Diarrhoea
Drug ineffective
Epistaxis (bleed from the nose)
Fatigue (feeling of tiredness)
Haematochezia (passage of stools containing blood)
Haematocrit decreased

male:

Cardiac failure congestive
Pericardial effusion (fluid around the heart)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Chills (felling of cold)
Feeling hot
Leukocytosis (increased white blood cells)
Oedema peripheral (superficial swelling)
Oesophageal carcinoma (cancer tumour of oesophagus)
Pyrexia (fever)
Rash

What are the common drug interactions of Irbesartan and Klor-Con M20, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Asthma
Platelet count decreased
Red blood cell count decreased
Red cell distribution width increased
White blood cell count decreased
Cardiac failure congestive
Pericardial effusion (fluid around the heart)
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Blepharitis (chronic inflammation of the eyelid)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 16.67%
Nausea And Vomiting: 2 people, 16.67%
Cardiac Disorder: 2 people, 16.67%
Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Breast Cancer Metastatic: 2 people, 16.67%
Pain: 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Breast Cancer Female: 1 person, 8.33%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan and Klor-con m20?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously